Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells

Blood

Volumn 108, Issue 13, 2006, Pages 4094-4101

  Fischer, Karin ^a   Voelkl, Simon ^b   Berger, Jana ^b   Andreesen, Reinhard ^b   Pomorski, Thomas ^b   Mackensen, Andreas ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELL CONTACT; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; LIPID RAFT; PRIORITY JOURNAL; SYNAPTIC MEMBRANE; T LYMPHOCYTE ACTIVATION;

EID: 33845512042     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-03-011742     Document Type: Article

References (46)

1. Devaux PF. Static and dynamic lipid asymmetry in cell membranes. Biochemistry. 1991;30:1163-1173.
2. Pomorski T, Holthuis JC, Herrmann A, van Meer G. Tracking down lipid flippases and their biological functions. J Cell Sci. 2004;117:805-813.
3. Schlegel RA, Williamson P. Phosphatidylserine, a death knell. Cell Death Differ. 2001;8:551-563.
4. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods. 1995;184:39-51.
5. Krysko O, De Ridder L, Cornelissen M. Phosphatidylserine exposure during early primary necrosis (oncosis) in JB6 cells as evidenced by immunogold labeling technique. Apoptosis. 2004;9:495-500.
6. van den Eijnde SM, Boshart L, Baehrecke EH, et al. Cell surface exposure of phosphatidylserine during apoptosis is phylogenetically conserved. Apoptosis. 1998;3:9-16.
7. Verhoven B, Krahling S, Schlegel RA, Williamson P. Regulation of phosphatidylserine exposure and phagocytosis of apoptotic T lymphocytes. Cell Death Differ. 1999;6:262-270.
8. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med. 1995;182:1597-1601.
9. Bratton DL, Fadok VA, Richter DA, et al. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J Biol Chem. 1997;272:26159-26165.
10. Gerke V, Moss SE. Annexins: from structure to function. Physiol Rev. 2002;82:331-371.
11. van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry. 1998;31:1-9.
12. Koopman G, Reutelingsperger CP, Kuijten GA, et al. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994;84:1415-1420.
13. 2+-induced activation of platelets from a patient with Scott syndrome. Br J Haematol. 1998;101:50-58.
14. Frasch SC, Henson PM, Nagaosa K, et al. Phospholipid flip-flop and phospholipid scramblase 1 (PLSCR1) co-localize to uropod rafts in formylated Met-Leu-Phe-stimulated neutrophils. J Biol Chem. 2004;279:17625-17633.
15. Dillon SR, Mancini M, Rosen A, Schlissel MS. Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol. 2000;164:1322-1332.
16. +-induced tyrosine phosphorylation and defective lipid scrambling in erythrocytes from a patient with Scott syndrome: a study using an inhibitor for scramblase that mimics the defect in Scott syndrome. Blood. 1998;91:2133-2138.
17. Kato N, Nakanishi M, Hirashima N. Transbilayer asymmetry of phospholipids in the plasma membrane regulates exocytotic release in mast cells. Biochemistry. 2002;41:8068-8074.
18. Williamson P, Christie A, Kohlin T, et al. Phospholipid scramblase activation pathways in lymphocytes. Biochemistry. 2001;40:8065-8072.
19. Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost. 2002;88:186-193.
20. Solum NO. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler Thromb Vasc Biol. 1999;19:2841-2846.
21. van den Eijnde SM, van den Hoff MJ, Reutelingsperger CP, et al. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J Cell Sci. 2001;114:3631-3642.
22. Bonomini M, Sirolli V, Gizzi F, et al. Enhanced adherence of human uremic erythrocytes to vascular endothelium: role of phosphatidylserine exposure. Kidney Int. 2002;62:1358-1363.
23. Manodori AB, Barabino GA, Lubin BH, Kuypers FA. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin. Blood. 2000;95:1293-1300.
24. Elliott JI, Surprenant A, Marelli-Berg FM, et al. Membrane phosphatidylserine distribution as a non-apoptotic signalling mechanism in lymphocytes. Nat Cell Biol. 2005;7:808-816.
25. Boon T, Coulie PG, Van den EB. Tumor antigens recognized by T cells. Immunol Today. 1997;18:267-268.
26. Mackensen A, Carcelain G, Viel S, et al. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Invest 1994;93:1397-1402.
27. Meidenbauer N, Marienhagen J, Laumer M, et al. Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients. J Immunol. 2003;170:2161-2169.
28. Salter RD, Howell DN, Cresswell P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics. 1985;21:235-246.
29. Meidenbauer N, Zippelius A, Pittet MJ, et al. High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome-deficient melanoma. Cancer Res. 2004;64:6319-6326.
30. Fischer K, Andreesen R, Mackensen A. An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity. J Immunol Methods. 2002;259:159-169.
31. Alcover A, Alarcon B. Internalization and intracellular fate of TCR-CD3 complexes. Crit Rev Immunol. 2000;20:325-346.
32. Fischer K, Mackensen A. The flow cytometric PKH-26 assay for the determination of T-cell mediated cytotoxic activity. Methods. 2003;31:135-142.
33. Revy P, Sospedra M, Barbour B, Trautmann A. Functional antigen-independent synapses formed between T cells and dendritic cells. Nat Immunol. 2001;2:925-931.
34. + responses triggered in T cells by dendritic cells compared with B cells. J Exp Med. 1998;188:1473-1484.
35. Gunzer M, Schafer A, Borgmann S, et al. Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity. 2000;13:323-332.
36. + CTLs. J Immunol. 1999;163:2601-2609.
37. Wei CH, Yagita H, Masucci MG, Levitsky V. Different programs of activation-induced cell death are triggered in mature activated CTL by immunogenic and partially agonistic peptide ligands. J Immunol. 2001;166:989-995.
38. + cells by Fas/Fas-ligand interaction. Sci World J. 2002;2:421-423.
39. Quintana A, Griesemer D, Schwarz EC, Hoth M. Calcium-dependent activation of T-lymphocytes. Pflugers Arch. 2005;450:1-12.
40. Rigotti A, Acton SL, Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem. 1995;270:16221- 16224.
41. Oka K, Sawamura T, Kikuta K, et al. Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells. Proc Natl Acad Sci U S A. 1998;95:9535-9540.
42. Fadok VA, Xue D, Henson P. If phosphatidylserine is the death knell, a new phosphatidylserine-specific receptor is the bellringer. Cell Death Differ. 2001;8:582-587.
43. Appelt U, Sheriff A, Gaipl US, et al. Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand annexin V to dying but not viable cells and implications for PS-dependent clearance. Cell Death Differ. 2005;12:194-196.
44. Borisenko GG, Matsura T, Liu SX, et al. Macrophage recognition of externalized phosphatidylserine and phagocytosis of apoptotic Jurkat cells - existence of a threshold. Arch Biochem Biophys. 2003;413:41-52.
45. Magee T, Pirinen N, Adler J, Pagakis SN, Parmryd I. Lipid rafts: cell surface platforms for T cell signaling. Biol Res. 2002;35:127-131.
46. Pike LJ, Han X, Chung KN, Gross RW. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry. 2002;41:2075-2088.